Skip to content
Press Releases
Filter Releases
 
Press Releases
Oct 20, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced that data presented at the 87th Annual Meeting of the American Thyroid Association (ATA) being held October 18-22 in Victoria, BC, Canada demonstrate the accuracy of identification of BRAF V600E and parathyroid tissue ...
PDF
Oct 19, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ:VCYT) today announced that data from a prospective clinical utility study demonstrating the ability of the Percepta® Bronchial Genomic Classifier to safely reduce unnecessary invasive procedures in lung cancer screening and diagno...
PDF
Oct 13, 2017
- The Coulter Foundation's Wallace H. Coulter Award for Healthcare Innovation Recognizes Excellence and Leadership in Clinical Diagnostic Medicine - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced today that the company's Chairman and ...
PDF
Oct 5, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that data from five studies validating the performance of the next-generation Afirma® Genomic Sequencing Classifier (GSC) in thyroid cancer diagnosis will be presented at the 87th Annual Meeting of the Ameri...
PDF
Sep 25, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that the Centers for Medicare & Medicaid Services (CMS) published preliminary 2018 rates for clinical diagnostic laboratory tests. The reimbursement rate for the Afirma Genomic Classifier (code 81545) is expected...
PDF
Sep 19, 2017
SOUTH SAN FRANCISCO, Calif. and RALEIGH, N.C., Sept. 19, 2017 /PRNewswire/ -- Veracyte, Inc. today announced the launch of Screen Together (www.ScreenTogether.com), an awareness campaign aimed at increasing routine screening among the millions of Americans at high risk for lung cancer. This unique campaign, introduced locally in partnership with th...
PDF
Sep 19, 2017
- Screen Together Campaign with Lung Cancer Initiative Underscores Company's Commitment to Improving Outcomes for People at High Risk of Lung Cancer - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that it has partnered with the ...
PDF
Sep 13, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at 2:15 p.m. Eastern Time in New York, NY. ...
PDF
Aug 24, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Morgan Stanley 15th Annual Global Healthcare Conference on Monday, September 11, 2017 at 5:25 p.m. Eastern Time in New York, NY. ...
PDF
Jul 31, 2017
Reports 25% Revenue Growth, to $18.4 Million, and 37% Improvement in Loss from Operations Over Prior Year Conference Call and Webcast Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the ...
PDF
Page:
...
Next Last